Ocugen has already approached Health Canada and submitted the Phase 3 clinical trial data of Covaxin seeking authorization to sell the jab in that country. “We have submitted all the data, what is needed for the submission — for Canadian submission.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.